Primorigen Biosciences, Inc. has entered into an exclusive worldwide distribution agreement with STEMCELL Technologies, Inc., of Vancouver, British Columbia, Canada. The agreement covers distribution of StemAdhere(TM), a new cell adhesion product developed and manufactured by Primorigen that promotes stem cell growth and pluripotency—the ability to become any cell type. The product is designed as a tool to help researchers focused on reversing conditions such as diabetes, Alzheimer’s Disease and other degenerative diseases.

Under the agreement, StemAdhere™ will be sold by STEMCELL Technologies under Primorigen’s Brand. Primorigen will continue to produce StemAdhere™ in its Madison, WI facilities, and STEMCELL Technologies will use its global sales network...